News | January 19, 2009

Society Honors Innovators in Breast Cancer Radiology, Radiation Therapy

Society Honors Innovators in Breast Cancer Radiology, Radiation Therapy

January 19, 2009 - The American Society of Breast Disease Pathfinder Lectures will honor Marie Overgaard, M.D., and Steve H. Parker, M.D. as part of the Society’s Annual Symposium, April 2-4, 2009, in Chicago, IL. In announcing the recipients of the Society’s only honorary recognition, American Society of Breast Disease president Julio A. Ibarra, M.D., noted that "through their vision and work this year’s honorees - Marie Overgaard and Steve H. Parker - have established new standards in diagnosis and treatment that have benefited the lives of millions of women around the world." Marie Overgaard, M.D., professor at Aarhus Hospital in Denmark, is the ASBD's 2009 Pathfinder Lecturer in Radiation Oncology. Her work in leading the large randomized trials of the Danish Breast Cancer Cooperative Group dramatically reshaped the hypothesis of breast cancer as a systemic disease. Through her research, Dr. Overgaard showed that post-mastectomy radiation with chemotherapy in both pre- and post-menopausal women positively impacted survival. Her studies of postoperative radiotherapy have earned her recognition as an honorary fellow in the American College of Radiology and the Gold Medal Award of the American Society for Radiation Oncology. The honoree for the 2009 ASBD Pathfinder Lecturer in Radiology is interventional radiologist Steve H. Parker, M.D., who is well known in the field of breast diagnosis. Dr. Parker has been a pioneer in the development and study of minimally invasive biopsy. His innovations have included stereotactic-guided core biopsy, ultrasound-guided core biopsy, stereotactic-guided vacuum assisted biopsy (VAB), ultrasound-guided VAB, ultrasound-guided sentinel node core biopsy/VAB and ultrasound-guided percutaneous excision of masses. While serving at Fitzsimons Army Medical Center, Dr. Parker developed the first use of image-guided percutaneous breast biopsy with a large-core needle. He was the principal author of a multi-institutional study showing that stereotactic and ultrasound large-core breast biopsy is as accurate as surgical biopsy. Dr. Parker further refined this technique by helping to develop additional minimally invasive tools, including VAB devices. Dr. Parker was the course director of the “Breast Imaging and Intervention in the 21st Century” international breast conference for 10 years and has lectured worldwide for the past two decades. Source: American Society of Breast Disease For more information: www.asbd.org

Related Content

Comparison of state Medicaid fees for radiation oncology services for breast cancer and nonradiation oncology services per the Kaiser Family Foundation Index

Fig. 1: Comparison of state Medicaid fees for radiation oncology services for breast cancer and nonradiation oncology services per the Kaiser Family Foundation Index. (Agarwal et al, Red Journal, 2019) Credit: Elsevier

News | Radiation Therapy | April 22, 2019
April 22, 2019 — A new study finds wide state
Stereotactic Radiosurgery Effective for Pediatric Arteriovenous Malformation Patients
News | Radiation Therapy | April 19, 2019
Ching-Jen Chen, M.D., of the neurosurgery department at the University of Virginia (UVA) Health System, was the winner...
Surgically Guided Brachytherapy Improves Outcomes for Intracranial Neoplasms
News | Brachytherapy Systems | April 18, 2019
Peter Nakaji, M.D., FAANS, general practice neurosurgeon at Barrow Neurological Institute, presented new research on...
ASTRO Applauds Introduction of PIMA Patient Protection Bill
News | Radiology Business | April 15, 2019
The American Society for Radiation Oncology (ASTRO) hailed the introduction of federal legislation that would...
Gamma Knife radiosurgery has become the preferred radiation therapy option for patients with brain tumors at facilities like the Northwestern Medicine Cancer Center, pictured here

Gamma Knife radiosurgery has become the preferred radiation therapy option for patients with brain tumors at facilities like the Northwestern Medicine Cancer Center, pictured here. The technology is favored largely for its ability to precisely target tumors while sparing healthy tissue.

Feature | Radiation Oncology | April 11, 2019 | By Jeff Zagoudis
Brain tumors are some of the most complicated forms of cancer to treat due to their extremely sensitive location.
Varian Discloses First Preclinical Results of Flash Therapy in Cancer Treatment
News | Proton Therapy | April 09, 2019
Varian, in partnership with the University of Maryland School of Medicine’s Department of Radiation Oncology and the...
Varian Halcyon Commissioned at MedStar Southern Maryland Hospital Center With IBA's myQA Halo
News | Quality Assurance (QA) | April 04, 2019
IBA (Ion Beam Applications S.A.) announced the successful commissioning of the Varian Halcyon at the Radiation Oncology...
Ikonopedia Introduces Automated Combined Reporting Package at SBI
News | Mammography Reporting Software | April 04, 2019
Ikonopedia will introduce its new Automated Combined Reporting package at the 2019 Society of Breast Imaging/American...
Konica Minolta Highlights New Exa Mammo Features at SBI/ACR Breast Imaging Symposium
News | Breast Imaging | April 03, 2019
Konica Minolta Healthcare Americas Inc. will highlight new features of Exa Mammo, a picture archiving and communication...